(NASDAQ:STIM) announced that management will participate at B. Riley Securities’ Mind, Muscle & Vision Summit, an ...

Summary: As the ancient adage goes, ‘a journey of a thousand miles begins with a single step’ — and India’s bold stride into ...

The US Food and Drug Administration's finalized guidance on psychedelic drug development signals the agency remains receptive ...

As the psychedelic drug industry shifts from a speculative niche to a potential part of mainstream healthcare, investors have ...

An in-depth look at the leading psychedelic stocks in the U.S. stock market this year. Here's what you need to know.

Cathie Wood's ARK added to its Meta Platforms (NASDAQ:META) position while further reducing its stake in Advanced Micro Devices (NASDAQ:AMD), according to the firm's daily trade disclosure released ...

At its core, Tabu is redefining how the world perceives her unconventional life and career by shifting the narrative from ...

COMPASS Pathways stock has delivered a very strong 1 year return, yet its current valuation checks and market multiples point ...

Compass Pathways plc upgraded to Strong Buy after phase 3 COMP360 TRD data & fast-track FDA NDA review; see catalysts, ...

Compass Pathways (CMPS) stock gains as Evercore ISI upgraded the company on the latest Phase 3 trial data for the company's ...

Compass Pathways stock reversed higher Tuesday on positive test results for its psychedelic drug in treatment-resistant depression.

Compass Pathways plc CMPS on Wednesday reported 26-week results from Part B of its Phase 3 COMP006 trial, reinforcing the ...